Vetulani J
Pol J Pharmacol Pharm. 1984 Mar-Jun;36(2-3):101-15.
Biochemical and behavioral studies on the mode of action of various antidepressant treatments supplied evidence that the effect of these treatments on cerebral neurotransmitter systems is more complex than it is assumed by the widely recognized "adrenoceptor down-regulation" hypothesis. As far as the central adrenergic system is concerned, it seems that antidepressant therapies in addition to down-regulation" of the beta-adrenergic system upregulate the alpha-adrenoceptor system. The facilitation of neurotransmission in alpha-adrenergic structures is affected by concomitant upregulation of alpha-1 adrenoceptors and downregulation of pre- and post-synaptic alpha-2 adrenoceptors. The action of antidepressant treatments is not limited to changes in adrenergic transmission, and the action of ECT on serotonergic and histaminergic system was also significant.
关于各种抗抑郁治疗作用方式的生化和行为学研究提供了证据,表明这些治疗对大脑神经递质系统的影响比广泛认可的“肾上腺素能受体下调”假说所设想的更为复杂。就中枢肾上腺素能系统而言,抗抑郁疗法除了使β-肾上腺素能系统“下调”外,似乎还上调了α-肾上腺素能受体系统。α-肾上腺素能结构中神经传递的促进受到α-1肾上腺素能受体的同时上调以及突触前和突触后α-2肾上腺素能受体下调的影响。抗抑郁治疗的作用不仅限于肾上腺素能传递的变化,电休克疗法对血清素能和组胺能系统的作用也很显著。